Innovative Solutions (NASDAQ:ISSC) reported quarterly earnings of $0.08 per share. This is a 50 percent decrease over earnings of $0.16 per share from the same period last year.
Bolt Biotherapeutics To Present Updates For 3 Preclinical Immuno-Oncology Pipeline Programs At American Association Of Cancer Research Meeting Apr. 8-13
Bolt Biotherapeutics (NASDAQ:BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology therapeutics that combine the targeting precision of antibodies with the power of both the innate and
